青海足弓模型南昌头颅骨模型,辽宁男性全身骨骼模型,海南高级吸痰练习模型,河北胸腔闭式引流术训练模型,贵阳人体躯干矢状断断层解剖模型,咸阳高级儿童手臂静脉穿刺训练模型,昭通小儿腹腔穿刺模型

The heat of summer is still toasting much of the U.S., but the chill of winter is around the corner, and if you believe Farmers' Almanac's projection, parts of the U.S. could be blasted with cold weather this winter. The Farmers' Almanac said almost all of the U.S. is projected to have below average temperatures, with the coldest weather coming in the Midwest and Northeast. Not only will the winter be colder, but it is expected to go deeper into the spring for the Midwest and Northeast.For more info on Farmers' Almanac's projections, click 558

The FDA said on Tuesday it has developed guidelines to take plasma from coronavirus survivors to treat patients who are critically ill from the virus. The FDA said on Tuesday that It is possible that convalescent plasma contains antibodies to the coronavirus and might be effective against the infection. The FDA said that although the announcement is promising, convalescent plasma has not been shown to be effective in every disease studied. The FDA is not approving using plasma as a treatment, instead using it as a clinical trial and for the treatment of those who are critically ill. "Given the public health emergency that the expanding COVID-19 outbreak presents, while clinical trials are being conducted, FDA is facilitating access to COVID-19 convalescent plasma for use in patients with serious or immediately life-threatening COVID-19 infections," the FDA said. The plasma will be collected from recovered individuals only if they are eligible to donate blood. The FDA said on Sunday that it was altering its guidelines on Risk Evaluation and Mitigation Strategy (REMS)-required testing, which allows healthcare providers to weigh the benefits of an experimental drug over its risks.“The FDA recognizes that during the COVID-19 public health emergency, the completion of some REMS-required laboratory testing or imaging studies may be difficult because patients suspected of having COVID-19 may be self-isolating and/or subject to quarantine,” said FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D. “Under these circumstances, undergoing testing or imaging studies in order to obtain a drug that is subject to a REMS can put patients and others at risk for transmission of the coronavirus. We will continue to work with sponsors to ensure that patients have appropriate access to the medications they need.” 1843

TEHRAN, Iran — Iran's state television has issued its most drastic warning so far about the new coronavirus, saying the outbreak could kill “millions” in the Islamic Republic if the public keeps traveling and ignoring health guidance. The warning came in a bulletin broadcast on Tuesday afternoon. Roughly nine out of 10 of the over 18,000 cases of the new virus confirmed across the Middle East come from Iran, where authorities denied for days the risk the outbreak posed. Iran's supreme leader also on Tuesday issued a religious order prohibiting “unnecessary” travel in the country. 599

The Food and Drug Administration said on Wednesday that some people and companies are trying to profit from this pandemic by selling unproven and illegally marketed products that make false claims, such as being effective against the coronavirus.The FDA says that products that claim to cure, treat, or prevent COVID-19 haven't been evaluated by the FDA for safety and effectiveness, and calls said products "dangerous."Wednesday's announcement comes two weeks after the FDA previously announced it sent letters to a number of companies that sell products that allegedly claim to treat or prevent coronavirus. Simply put, if there are any products that claim to treat or cure coronavirus, the FDA says not to buy it."The FDA is working with medical product developers to rapidly advance the development and availability of vaccines and treatments for COVID-19. Although there are investigational COVID-19 vaccines and treatments being studied in clinical trials, these products are in the early stages of development. They haven't yet been fully tested for safety or effectiveness, or received FDA approval," the FDA said on Wednesday,' the FDA said. The FDA is requesting the public to report suspected fraud to the FDA's 1235

The House Oversight Committee voted on Wednesday to hold Attorney General William Barr and Commerce Secretary Wilbur Ross in contempt of Congress over a dispute related to the addition of a citizenship question to the 2020 census. The vote was 24-15.The Democratic-led committee voted on a contempt resolution that recommends that the House of Representatives find Barr and Ross in contempt of Congress "for refusal to comply with subpoenas." The contempt resolution includes citations for both civil and criminal contempt.It's unclear what will happen now that the committee has voted on the resolution. Depending on how the Departments of Justice or Commerce respond, House Democrats could go to the floor with both criminal and civil contempt. They could also drop criminal before going to the floor if some accommodation happens.According to a committee aide, a criminal contempt vote would have to go through the floor. However, civil contempt could go through the Bipartisan Legal Advisory Group, which is made up of the three highest-ranked House Democrats and two highest-ranked House Republicans.Earlier on Wednesday, the Department of Justice informed the House Oversight Committee on Wednesday that President Donald Trump has asserted executive privilege over materials related to the addition of a citizenship question to the 2020 census.In a letter to Committee Chair Elijah Cummings, Assistant Attorney General Stephen Boyd 1450